These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 453214)

  • 61. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin].
    Chang SC; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647
    [No Abstract]   [Full Text] [Related]  

  • 62. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.
    Jenne JW; Wyze MS; Rood FS; MacDonald FM
    Clin Pharmacol Ther; 1972; 13(3):349-60. PubMed ID: 5026376
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effect of slow-release aminophylline on pulmonary function in obstructive respiratory disease(author's transl)].
    Wiessmann KJ
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1781-90. PubMed ID: 1098887
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comparative assessment of three bronchodilator preparations in general practice.
    Maneksha S
    J Int Med Res; 1979; 7 Suppl 1():62-6. PubMed ID: 437309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of obstructive respiratory disorders using a new theophylline retard preparation].
    Schroers M; Merbach W; Don M
    ZFA (Stuttgart); 1982 Jun; 58(17):974-8. PubMed ID: 7113392
    [No Abstract]   [Full Text] [Related]  

  • 66. Theophylline: biochemical pharmacology and pharmacokinetics.
    Trembath PW; Boobis SW; Richens A
    J Int Med Res; 1979; 7 Suppl 1():4-15. PubMed ID: 220119
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
    Dorow P
    Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A multiple-dose study of sustained-release theophylline and aminophylline.
    Meyer MC; Straughn AB; Lieberman P
    Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
    Geisler LS; Thiel H; Förster OB; Rohner HG
    Dtsch Med Wochenschr; 1980 Jun; 105(25):894-7. PubMed ID: 7408664
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Relationship among dosages of aminophylline, plasma levels of theophylline and variation of pulmonary arterial pressure].
    Liu S; Chen W; Luo Y; Yuan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):87-90. PubMed ID: 1398633
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Favorable cardiovascular effects of theophylline in COPD.
    Matthay RA
    Chest; 1987 Jul; 92(1 Suppl):22S-26S. PubMed ID: 3297523
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Determination of serum theophylline concentration in ambulatory practice].
    Staib AH; Rietbrock N; Neiss A
    Dtsch Med Wochenschr; 1985 Apr; 110(17):680-5. PubMed ID: 3987532
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis.
    Reisz G; Pingleton SK; Melethil S; Ryan PB
    Am Rev Respir Dis; 1983 May; 127(5):581-4. PubMed ID: 6846940
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Relation between indicators of respiratory tract patency and intrapulmonary distribution of ventilation in patients with chronic obstructive bronchopulmonary disease after combined administration of aminophylline and fenoterol].
    Mayer M; Dúbrava I; Strmen J; Dúbravová H
    Bratisl Lek Listy; 1987 May; 87(5):606-15. PubMed ID: 3651856
    [No Abstract]   [Full Text] [Related]  

  • 75. [Lung functions and blood levels after parenteral administration of theophylline-ethylenediamine (author's transl)].
    Wiessmann KJ; Schulz HU
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1916-20. PubMed ID: 598301
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical use of controlled-release theophylline in chronic airways obstruction.
    Dal Negro R; Turco P; Pomari C; Cordaro CI
    J Int Med Res; 1987; 15(6):391-6. PubMed ID: 3436486
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circadian changes in the absorption and elimination of theophylline in patients with bronchial obstruction.
    Uematsu T; Follath F; Vozeh S
    Eur J Clin Pharmacol; 1986; 30(3):309-12. PubMed ID: 3732366
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies].
    Philip-Joet F; Bruguerolle B; Parrel M; Vestri R; Arnaud A
    Presse Med; 1988 Feb; 17(5):193-6. PubMed ID: 2965374
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical experience with two twice daily slow release theophylline preparations. Relation between serum theophylline concentrations, effectiveness, tolerability and compliance in elderly patients.
    Ruggeri S; Bernocchi D; Berte F; D'Anneo R; Gramolini C
    J Int Med Res; 1987; 15(3):170-8. PubMed ID: 3301457
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Accidental coadministration of intravenous aminophylline and theophylline by mouth: a hazardous practice.
    Frewin DB; Cooper DJ
    Med J Aust; 1986 Apr; 144(9):481-2. PubMed ID: 3702795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.